Hyderabad: The monkey menace, which was a key issue for several sarpanch candidates in the recently concluded panchayat polls ...

The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Our livestock experts explain how beef and sheep farmers are set to be impacted by Defra's new animal welfare strategy.

GEN lists the top five performing biotech stocks of 2025 and the five biotech stocks that fell the most during this past year, with brief explanations for the increases or declines.

Chemotherapy remains vital in metastatic castration-resistant prostate cancer (mCRPC) despite androgen receptor pathway inhibitors (ARPIs), poly (ADP-ribose) polymerase (PARP) inhibitors, and ...

Daniel Kelly does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Last year, Louisiana became the first state to authorize surgical castration for child molesters. Last month, Thomas Allen McCartney, a convicted serial child rapist, was sentenced to both surgical ...

Unlike chemical castration, which surpresses hormone production without removing organs, this procedure removes testicles in men and ovaries in women, according to Cleveland Clinic. If the court ...

This article was originally published by The Marshall Project. Last year, Louisiana sparked a slew of sensational headlines when state legislators passed a law allowing surgical castration as ...

This is The Marshall Project’s Closing Argument newsletter, a weekly deep dive into a key criminal justice issue. Want this delivered to your inbox? Sign up for future newsletters. This March, ...

NUBEQA ® (darolutamide) is the first and only androgen receptor inhibitor (ARi) to show clinically meaningful delays in deterioration of important patient-relevant health-related quality of life ...